2023.9Introductionto

RespiratorySystemJiemingQu第1頁(yè)IntroductionTheRespiratorySystemStructureDetail

2第2頁(yè)Introduction3第3頁(yè)IntroductionDeathRateof10MainDiseasesinCertainRegionin2023(China)

Rank

City

County

CauseDeathRate1/100000

%

CauseDeathRate1/100000

%

12345678910MalignantNeoplasmsCerebrovascularDiseaseHeartDiseaseDiseasesoftheRespiratorySystemInjury&PoisoningEndocrine,Nutritional&MetabolicDiseasesDiseasesoftheDigestiveSystemDiseaseoftheGenitourinarySystemDiseaseoftheNervousSystemMentalDisorders

144.5793.6990.7269.2932.3617.5915.617.284.953.4427.2517.6617.1013.066.103.322.941.370.930.65MalignantNeoplasmsCerebrovascularDiseaseDiseasesoftheRespiratorySystemHeartDiseaseInjury&PoisoningDiseasesoftheDigestiveSystemEndocrine,Nutritional&MetabolicDiseasesDiseaseoftheGenitourinarySystemDiseaseoftheNervousSystemMentalDisorders

130.23105.4884.9471.8446.1217.008.166.654.163.7725.1420.3616.4013.878.903.281.571.280.800.73Total90.41Total92.324第4頁(yè)Majortasks:

Whatdisease?(disease’sdiagnosis)Howtodealwithit?(disease’smanagement)5第5頁(yè)ClinicalPresentation6第6頁(yè)Commonpresentingsymptoms:Dyspnea(shortnessofbreath)CoughLesscommonsymptoms:Hemoptysis(thecoughingupofblood)Chestpain(oftenwithapleuriticcharacteristics)History7第7頁(yè)Acute(overaperiodofhourstodays):

AcuteattackofasthmaAcutepulmonaryedemaBacterialpneumoniaPneumothoraxPulmonaryembolusHistoryDyspnea8第8頁(yè)Subacute(overdaystoweeks):AsthmaChronicbronchitisPleuraleffusionCongestiveheartfailurePneumocystiscariniipneumoniainpatientswithAIDSWegener'sgranulomatosis,eosinophilicpneumonia,BronchiolitisobliteranswithorganizingpneumoniaGuillain-Barresyndrome,myastheniagravis

HistoryDyspnea9第9頁(yè)Chronic(overmonthstoyears):

COPDChronicinterstitiallungdiseaseChroniccardiacdiseaseHistoryDyspnea10第10頁(yè)

Acuteorchronic?

Seasonalorassociatedwithwheezing?Associatedwithsymptomssuggestiveofpostnasaldriporgastroesophagealreflux?Associatedwithfeverorsputum?Anyassociateddiseasesorriskfactorsfordisease(e.g.,cigarettesmoking,riskfactorsforinfectionwithHIV,environmentalexposures)?HistoryCough11第11頁(yè)Originatingfromtheairways:

Bronchitis,Bronchiectasis,Cysticfibrosis,Bronchogeniccarcinoma,BronchialcarcinoidtumorsOriginatingfromthepulmonaryparenchyma:Pneumonia,Lungabscess,Tuberculosis,InfectionwithAspergillus,Goodpasture’ssyndrome,Idiopathicpulmonaryhemosiderosis(IPH)Originatingfromthevasculature:Thromboembolicdiseases,ArteriovenousmalformationsHistoryHemoptysis12第12頁(yè)Usuallyoriginatingfrominvolvementoftheparietalpleura:PleuritisPneumothoraxNeoplasmPulmonaryembolismPneumoniaHistoryChestpain13第13頁(yè)

ThenumberofyearsofsmokingTheintensity(i.e.,numberofpacksperday)TheintervalsincesmokingcessationAhistoryofsignificantsecondhand(passive)exposuretosmokeHistoryHistoryofsmoking14第14頁(yè)Respiratorydisordersassociatedwithsmoking:ChronicobstructivelungdiseaseNeoplasiaSpontaneouspneumothoraxRespiratorybronchiolitis-interstitiallungdiseaseEosinophilicgranulomaofthelungPulmonaryhemorrhagewithGoodpasture'ssyndromeHistoryHistoryofsmoking15第15頁(yè)

Occupational(detailedoccupationalandpersonalhistories)orAvocational(hobbies,homeenvironment)

Inorganicdusts(asbestos,silicadusts)associatedwithpneumoconiosiswhileorganicantigens(molds,animalproteins)associatedwithhypersensitivitypneumonitisHistoryExposuretoinhaledagents16第16頁(yè)

Systemicrheumaticdiseases

RiskfactorsforAIDS

Treatmentofnonrespiratorydisease(immunosuppressiveagents,cancerchemotherapy,radiationtherapy,amiodarone,?-blockingagents,angiotensin-convertingenzymeinhibitors(ACEI))

HistoryCoexistingnonrespiratorydiseases17第17頁(yè)Geneticcomponent:

Cysticfibrosisα1-antitrypsindeficiencyPulmonaryhypertensionPulmonaryfibrosisAsthmaHistoryFamilyhistory18第18頁(yè)

TherateandpatternofbreathingThedepthandsymmetryoflungexpansionPhysicalExaminationInspection19第19頁(yè)

Thesymmetryoflungexpansion,confirmingthefindingsobservedbyinspectionVibrationproducedbyspokensoundsFocaltendernessPhysicalExaminationPalpation20第20頁(yè)

TherelativeresonanceordullnessofthetissueunderlyingthechestwallPhysicalExaminationPercussion21第21頁(yè)

ThequalityandintensityofthebreathsoundsThepresenceofextra,oradventitioussoundsTheprimaryadventitious(abnormal)soundsthatcanbeheardincludecrackles(rales),wheezes,andrhonchiOtheradventitioussoundsincludepleuralfrictionrubsandstridorPhysicalExaminationAuscultation22第22頁(yè)P(yáng)hysicalExaminationTypicalChestExaminationFindingsinSelectedClinicalConditionsPercussionTactileFremitusBreathSoundsVocalResonanceAdventitiousSoundsConsolidationoratelectasis(withpatentairway)DullIncreasedBronchialBronchophony,whisperedpectoriloquy,egophonyCracklesConsolidationoratelectasis(withblockedairway)DullDecreasedDecreasedDecreasedAbsentAsthmaResonantNormalVesicularNormalWheezingInterstitiallungdiseaseResonantNormalVesicularNormalCracklesEmphysemaHyperresonantDecreasedDecreasedDecreasedAbsentorWheezingPneumothoraxHyperresonantDecreasedDecreasedDecreasedAbsentPleuraleffusionDullDecreasedDecreasedDecreasedAbsentorpleuralfrictionrub23第23頁(yè)AdditionalDiagnosticEvaluation24第24頁(yè)

Collectedeitherbyspontaneousexpectorationorafterinhalationofanirritatingaerosol,suchashypertonicsalineQualifiedsample:Squamousepithelialcells<10/HP,WBC>25/HPorWBC/Squamousepithelialcells>2.5

CollectionofSputum25第25頁(yè)

Stainingandcultureformycobacteriaorfungi

Cultureforviruses

StainingforPneumocystiscarinii(especiallyinapatientinfectedwithHIV)

CytologicstainingformalignantcellsTheuseofpolymerasechainreaction(PCR)amplificationandDNAprobesCollectionofSputum26第26頁(yè)ArterialBloodGasesMechanismsofhypoxemia:AdecreaseininspiredPO2HypoventilationShuntingV/Qmismatching27第27頁(yè)ArterialBloodGasesMechanismofhypercapnia:IncreasedCO2productionDecreasedventilatorydrive("won'tbreathe")Malfunctionoftherespiratorypumporincreasedairwaysresistance("can'tbreathe")Inefficiencyofgasexchange(increaseddeadspaceorV/Qmismatch)28第28頁(yè)RoutineRadiographyPosteroanterior(PA)DIL29第29頁(yè)RoutineRadiographyAnteroposterior(AP)ARDS30第30頁(yè)ChestRadiographyRheumatoidnodule(oneorseveralnodules):Vascularmalformation,BronchogeniccystLocalizedopacification(infiltrate):Pneumonia(bacterial,atypical,mycobacterial,orfungalinfection),Neoplasm,Radiationpneumonitis,Bronchiolitisobliteranswithorganizingpneumonia(BOOP),Bronchocentricgranulomatosis,PulmonaryinfarctionMajorRespiratoryDiagnoseswithCommonChestRadiographicPatterns(1)31第31頁(yè)ChestRadiography

MajorRespiratoryDiagnoseswithCommonChestRadiographicPatterns(1)

Diffuseinterstitialdisease:Idiopathicpulmonaryfibrosis,Pulmonaryfibrosiswithsystemicrheumaticdisease,Sarcoidosis,Drug-inducedlungdisease,Pneumoconiosis,Hypersensitivitypneumonitis,Infection(Pneumocystis,viralpneumonia),Eosinophilicgranuloma32第32頁(yè)ChestRadiographyDiffusealveolardisease:Cardiogenicpulmonaryedema,AcuterespiratorydistresssyndromeDiffusealveolarhemorrhage:Infection(Pneumocystis,viralorbacterialpneumonia),SarcoidosisDiffusenodulardisease:Metastaticneoplasm,Hematogenousspreadofinfection(bacterial,mycobacterial,fungal),Pneumoconiosis,EosinophilicgranulomaMajorRespiratoryDiagnoseswithCommonChestRadiographicPatterns(2)33第33頁(yè)ComputedTomography

DistinguishingvariousdensitiesParticularlyvaluableinassessinghilarandmediastinaldiseaseIdentifyingareasoffatdensityorcalcificationinpulmonarynodulesAssessmentinthestagingoflungcancerDistinguishingvascularfromnonvascularstructures34第34頁(yè)CTscandemonstratingamediastinalmassComputedTomography35第35頁(yè)High-resolutionCTscanfromapatientwithidiopathicpulmonaryfibrosis.scatteredreticulardensities(arrows)ComputedTomography36第36頁(yè)Idiopathicpulmonaryfibrosis.High-resolutionCTimageshowsbibasal,peripheralpredominantreticularabnormalitywithTractionbronchiectasisandhoneycombingComputedTomography37第37頁(yè)exudativephaseofARDSinwhichdependentalveolaredemaandatelectasispredominateComputedTomography38第38頁(yè)ComputedTomography

HelicalCTscanningCTangiographyHigh-resolutionCT(HRCT),thethicknessofindividualcrossisapproximately1to2mmVirtualbronchoscopy39第39頁(yè)P(yáng)ET

Positronemissiontomographic(PET)scanning

isincreasinglybeingusedtoidentifymalignantlesionsinthelungbasedontheirincreaseduptakeandmetabolismofglucoseThetechniqueinvolvesinjectionofaradiolabeledglucoseanalogue,18F-fluoro-2-deoxyglucose

(FDG),whichistakenupbymetabolicallyactivemalignantcells40第40頁(yè)P(yáng)ulmonaryAngiography

ThepulmonaryarterialsystemcanbevisualizedIncasesofpulmonaryembolism,pulmonaryangiographydemonstratestheconsequencesofanintravascularclot—eitheradefectinthelumenofavessel(a"fillingdefect")oranabrupttermination("cutoff")ofthevesselWithadvancesinCT1scanning,traditionalpulmonaryangiographyisincreasinglybeingreplacedbyCTangiography41第41頁(yè)ThoracentesisEffusiontobeclassifiedaseitherexudativeortransudativeExudativepleuraleffusionsmeetatleastoneofthefollowingcriteria:pleuralfluidprotein/serumprotein>0.5pleuralfluidLDH/serumLDH>0.6

pleuralfluidLDHmorethantwo-thirdsnormalupperlimitforserum42第42頁(yè)P(yáng)ulmonaryFunctionTestThetwomeasurementsoflungvolumecommonlyusedforrespiratorydiagnosis:Totallungcapacity(TLC)Residualvolume(RV)ThevolumeofgasthatisexhaledfromthelungsingoingfromTLCtoRVisthevitalcapacity(VC)DisturbancesinVentilatoryFunction43第43頁(yè)P(yáng)ulmonaryFunctionTestLungvolumes,shownbyblockdiagrams(left)andbyaspirographictracing(right)*Totallungcapacity(TLC)*Vitalcapacity(VC)*Residualvolume(RV)*Inspiratorycapacity(IC)*Expiratoryreservevolume(ERV)*Functionalresidualcapacity(FRC)DisturbancesinVentilatoryFunction44第44頁(yè)P(yáng)ulmonaryFunctionTestanormaltracing(A)obstructive(B)parenchymalrestrictive(C)Disease*Forcedvitalcapacity(FVC)*Forcedexpiratoryvolume(FEV)*Forcedexpiratoryflow(FEF)DisturbancesinVentilatoryFunction45第45頁(yè)P(yáng)ulmonaryFunctionTestThreemaincategoriesofdiseaseareassociatedwithloweredDLCO:InterstitiallungdiseaseEmphysemaPulmonaryvasculardiseaseAnelevatedDLCOmaybeusefulinthediagnosisofalveolarhemorrhage,asinGoodpasture'ssyndromeDiffusingCapacity46第46頁(yè)P(yáng)ulmonaryFunctionTestFlow-volumecurvesindifferentconditions:O,obstructivedisease;R(P),